ATE486099T1 - Antiallergische herstellung von latex oder pvc und formgebungsverfahren dafür - Google Patents

Antiallergische herstellung von latex oder pvc und formgebungsverfahren dafür

Info

Publication number: ATE486099T1
Authority: AT; Austria
Prior art keywords: latex; pvc; antiallergic; present; condom
Prior art date: 2005-04-15

Application number

AT05818716T

Other languages

English (en)

Inventor

Zhengming Zhou

Yan Jiang

Original Assignee

Zhengming Zhou

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-04-15

Filing date

2005-12-09

Publication date

2010-11-15

2005-04-15 Priority claimed from CNB2005100388959A external-priority patent/CN100355375C/zh

2005-05-16 Priority claimed from CNB2005100400255A external-priority patent/CN100486546C/zh

2005-12-09 Application filed by Zhengming Zhou filed Critical Zhengming Zhou

2010-11-15 Application granted granted Critical

2010-11-15 Publication of ATE486099T1 publication Critical patent/ATE486099T1/de

Links

230000003266 anti-allergic effect Effects 0.000 title abstract 4
239000004816 latex Substances 0.000 title abstract 4
238000004519 manufacturing process Methods 0.000 title 1
238000000034 method Methods 0.000 title 1
238000000465 moulding Methods 0.000 title 1
229920000126 latex Polymers 0.000 abstract 3
WVTKBKWTSCPRNU-KYJUHHDHSA-N (+)-Tetrandrine Chemical compound C([C@H]1C=2C=C(C(=CC=2CCN1C)OC)O1)C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@@H]2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-KYJUHHDHSA-N 0.000 abstract 2
MFIHSKBTNZNJIK-RZTYQLBFSA-N (3s,3ar,6s,6ar)-3-(3,4-dimethoxyphenyl)-6-(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan Chemical compound C1=C(OC)C(OC)=CC=C1[C@@H]1[C@@H](CO[C@@H]2C=3C=C(OC)C(OC)=C(OC)C=3)[C@@H]2CO1 MFIHSKBTNZNJIK-RZTYQLBFSA-N 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
238000000605 extraction Methods 0.000 abstract 2
PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 abstract 1
NQWVSMVXKMHKTF-JKSUJKDBSA-N (-)-Arctigenin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O)=CC=2)C(=O)OC1 NQWVSMVXKMHKTF-JKSUJKDBSA-N 0.000 abstract 1
MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 abstract 1
241000242759 Actiniaria Species 0.000 abstract 1
YYGRXNOXOVZIKE-UHFFFAOYSA-N Arctigenin Natural products COC1CCC(CC2COC(=O)C2CC3CCC(O)C(C3)OC)CC1OC YYGRXNOXOVZIKE-UHFFFAOYSA-N 0.000 abstract 1
241001002544 Engelhardia Species 0.000 abstract 1
JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 abstract 1
235000011201 Ginkgo Nutrition 0.000 abstract 1
235000008100 Ginkgo biloba Nutrition 0.000 abstract 1
244000194101 Ginkgo biloba Species 0.000 abstract 1
244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
OIFFJDGSLVHPCW-UHFFFAOYSA-N Guayarol Natural products COc1ccc(CC2C(Cc3ccc(O)c(O)c3)COC2=O)cc1OC OIFFJDGSLVHPCW-UHFFFAOYSA-N 0.000 abstract 1
206010020751 Hypersensitivity Diseases 0.000 abstract 1
ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 abstract 1
NQWVSMVXKMHKTF-UHFFFAOYSA-N L-Arctigenin Natural products C1=C(OC)C(OC)=CC=C1CC1C(CC=2C=C(OC)C(O)=CC=2)C(=O)OC1 NQWVSMVXKMHKTF-UHFFFAOYSA-N 0.000 abstract 1
ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 abstract 1
241000245050 Menispermum Species 0.000 abstract 1
YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 abstract 1
MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 abstract 1
IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 abstract 1
HPUXDMUGCAWDFW-UHFFFAOYSA-N Osthole Natural products COc1ccc2CCC(=O)Oc2c1C=CC(=O)C HPUXDMUGCAWDFW-UHFFFAOYSA-N 0.000 abstract 1
244000269722 Thea sinensis Species 0.000 abstract 1
229930013930 alkaloid Natural products 0.000 abstract 1
150000003797 alkaloid derivatives Chemical class 0.000 abstract 1
208000026935 allergic disease Diseases 0.000 abstract 1
IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 abstract 1
229960003321 baicalin Drugs 0.000 abstract 1
AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 abstract 1
ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 abstract 1
235000005487 catechin Nutrition 0.000 abstract 1
229950001002 cianidanol Drugs 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
229930182470 glycoside Natural products 0.000 abstract 1
150000002338 glycosides Chemical class 0.000 abstract 1
230000009610 hypersensitivity Effects 0.000 abstract 1
235000011477 liquorice Nutrition 0.000 abstract 1
-1 liquorice saponin Chemical class 0.000 abstract 1
229930014456 matrine Natural products 0.000 abstract 1
239000011159 matrix material Substances 0.000 abstract 1
MFIHSKBTNZNJIK-UHFFFAOYSA-N medioresinol dimethyl ether Natural products C1=C(OC)C(OC)=CC=C1C1C(COC2C=3C=C(OC)C(OC)=C(OC)C=3)C2CO1 MFIHSKBTNZNJIK-UHFFFAOYSA-N 0.000 abstract 1
NWFYESYCEQICQP-UHFFFAOYSA-N methylmatairesinol Natural products C1=C(OC)C(OC)=CC=C1CC1C(=O)OCC1CC1=CC=C(O)C(OC)=C1 NWFYESYCEQICQP-UHFFFAOYSA-N 0.000 abstract 1
229940100243 oleanolic acid Drugs 0.000 abstract 1
MBRLOUHOWLUMFF-UHFFFAOYSA-N osthole Chemical compound C1=CC(=O)OC2=C(CC=C(C)C)C(OC)=CC=C21 MBRLOUHOWLUMFF-UHFFFAOYSA-N 0.000 abstract 1
150000008442 polyphenolic compounds Chemical class 0.000 abstract 1
235000013824 polyphenols Nutrition 0.000 abstract 1
HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 abstract 1
239000001397 quillaja saponaria molina bark Substances 0.000 abstract 1
WVTKBKWTSCPRNU-UHFFFAOYSA-N rac-Tetrandrin Natural products O1C(C(=CC=2CCN3C)OC)=CC=2C3CC(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2CC2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-UHFFFAOYSA-N 0.000 abstract 1
229930182490 saponin Natural products 0.000 abstract 1
NCTHNHPAQAVBEB-WGCWOXMQSA-M sodium ferulate Chemical compound [Na+].COC1=CC(\C=C\C([O-])=O)=CC=C1O NCTHNHPAQAVBEB-WGCWOXMQSA-M 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L7/00—Compositions of natural rubber
- C08L7/02—Latex
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A41D19/00—Gloves
- A41D19/0055—Plastic or rubber gloves
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/02—Contraceptive devices; Pessaries; Applicators therefor for use by males
- A61F6/04—Condoms, sheaths or the like, e.g. combined with devices protecting against contagion
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08C—TREATMENT OR CHEMICAL MODIFICATION OF RUBBERS
- C08C1/00—Treatment of rubber latex
- C08C1/02—Chemical or physical treatment of rubber latex before or during concentration
- C08C1/04—Purifying; Deproteinising

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Vascular Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Reproductive Health (AREA)
Heart & Thoracic Surgery (AREA)
Medicinal Chemistry (AREA)
Polymers & Plastics (AREA)
Organic Chemistry (AREA)
Textile Engineering (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Medicinal Preparation (AREA)
Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Moulding By Coating Moulds (AREA)

AT05818716T 2005-04-15 2005-12-09 Antiallergische herstellung von latex oder pvc und formgebungsverfahren dafür ATE486099T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
CNB2005100388959A CN100355375C (zh)	2005-04-15	2005-04-15	药物手套及其制备方法
CNB2005100400255A CN100486546C (zh)	2005-05-16	2005-05-16	防过敏避孕套及其制备方法
PCT/CN2005/002137 WO2006108333A1 (en)	2005-04-15	2005-12-09	Antiallergic production of latex or pvc and method for forming the same

Publications (1)

Publication Number	Publication Date
ATE486099T1 true ATE486099T1 (de)	2010-11-15

Family

ID=37086601

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05818716T ATE486099T1 (de)	2005-04-15	2005-12-09	Antiallergische herstellung von latex oder pvc und formgebungsverfahren dafür

Country Status (7)

Country	Link
US (1)	US20080166383A1 (de)
EP (1)	EP1870426B1 (de)
JP (1)	JP2008532717A (de)
AT (1)	ATE486099T1 (de)
DE (1)	DE602005024451D1 (de)
RU (1)	RU2369619C2 (de)
WO (1)	WO2006108333A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2897038C (en)	2014-07-14	2016-10-04	Novicol International Holding Inc.	Microbicidal composition comprising an octoxynol and a quinolizidine alkaloid compound or a source thereof
DE102020203988A1 (de) *	2020-03-27	2021-09-30	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein	Verwendung von Hydroxyzimtsäuresalzen zur Stabilisierung von organischen Materialien, stabilisiertes organisches Material, Verfahren zur Stabilisierung von organischen Materialien, spezifische Stabilisatoren sowie Stabilisatorzusammensetzungen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS60188315A (ja) *	1984-03-07	1985-09-25	Yamanouchi Pharmaceut Co Ltd	グリチルレチン酸配合鎮痒プラスター
JP2627666B2 (ja) *	1989-07-13	1997-07-09	花王株式会社	抗アレルギー剤
US5539021A (en) *	1995-06-05	1996-07-23	The Dow Chemical Company	Process for preparing high internal phase ratio emulsions and latexes derived thereof
JPH11106569A (ja) *	1997-10-02	1999-04-20	Erubu:Kk	抗菌性ゴムおよび抗菌性ゴムラテックス
CN1352593A (zh) *	1997-10-20	2002-06-05	生物屏障公司	形成包括多层不连续层的乳胶或聚合物膜的方法
WO2000050507A1 (en) *	1999-02-24	2000-08-31	Cognis Corporation	Reduction of latex associated hypersensitivity
JP2000308519A (ja) *	1999-04-27	2000-11-07	Erubu:Kk	化粧用パフおよびその製造法
US6436991B1 (en) *	2000-05-19	2002-08-20	Sabinsa Corporation	Composition and method containing products extracted from Commiphora sp. for prevention and treatment of abnormal cell growth and proliferation in inflammation, neoplasia and cardiovascular disease
JP2003027083A (ja) *	2001-07-19	2003-01-29	Okamoto Ind Inc	コンドーム用潤滑剤及びコンドーム
US20030212167A1 (en) *	2002-05-08	2003-11-13	Teknor Apex Company	Oxygen-scavenging polymer compositions
CN1557351A (zh) *	2004-01-16	2004-12-29	玲张	红外消痛功能性绷带

2005
- 2005-12-09 AT AT05818716T patent/ATE486099T1/de not_active IP Right Cessation
- 2005-12-09 DE DE602005024451T patent/DE602005024451D1/de not_active Expired - Lifetime
- 2005-12-09 WO PCT/CN2005/002137 patent/WO2006108333A1/zh not_active Ceased
- 2005-12-09 EP EP05818716A patent/EP1870426B1/de not_active Expired - Lifetime
- 2005-12-09 JP JP2008502223A patent/JP2008532717A/ja active Pending
- 2005-12-09 US US11/911,379 patent/US20080166383A1/en not_active Abandoned
- 2005-12-09 RU RU2007142179/04A patent/RU2369619C2/ru not_active IP Right Cessation

Also Published As

Publication number	Publication date
WO2006108333A1 (en)	2006-10-19
JP2008532717A (ja)	2008-08-21
EP1870426A4 (de)	2009-02-11
EP1870426A1 (de)	2007-12-26
US20080166383A1 (en)	2008-07-10
DE602005024451D1 (de)	2010-12-09
RU2007142179A (ru)	2009-05-20
RU2369619C2 (ru)	2009-10-10
EP1870426B1 (de)	2010-10-27

Legal Events

Date	Code	Title	Description
2011-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
Srivastava et al.	2019	Phytomedicine: A potential alternative medicine in controlling neurological disorders
Mao et al.	2008	Antidepressant‐like effect of ethanol extract from Paeonia lactiflora in mice
Han et al.	2002	Free radical scavenging effect of Diospyros kaki, Laminaria japonica and Undaria pinnatifida
Deng et al.	2023	Anti-neuroinflammatory potential of natural products in the treatment of Alzheimer’s disease
El-Awady et al.	2015	Evaluation of the anticancer activities of pomegranate (Punica granatum) and harmal (Rhazya stricta) plants grown in Saudi arabia
Shamsizadeh et al.	2017	The role of natural products in the prevention and treatment of multiple sclerosis
WO2011026606A3 (en)	2011-06-23	Composition for the treatment of hemorrhoids and related diseases
Goel	2025	Exploring the therapeutic role of Moringa oleifera in neurodegeneration: antioxidant, anti-inflammatory, and neuroprotective mechanisms: Exploring the therapeutic role of Moringa oleifera in neurodegeneration
Hajare et al.	2015	Antibacterial activity of the leaves of Bougainvillea spectabilis against E. coli NCIM 2832 and M. aureus NCIM 5021
Sharma et al.	2021	Alzheimer’s disease: ethanobotanical studies
Akuodor et al.	2014	Phytochemical and anti-diarrhoeal properties of methanolic leaf extract of Maerua crassifolia Forssk.
CN105996288A (zh)	2016-10-12	环保除脚臭保健功能鞋的制作方法
ATE486099T1 (de)	2010-11-15	Antiallergische herstellung von latex oder pvc und formgebungsverfahren dafür
KR20170133859A (ko)	2017-12-06	독감 치료용 한약
Roychoudhury et al.	2020	Health benefits of plant derived bioactive secondary metabolites as dietary constituents
Giri et al.	2020	Antiparkinsonian and antioxidant effects of hydroalcoholic extract of Camellia sinensis, Asparagus racemosus, Mucuna pruriens and their combination
Gospodinova et al.	2014	In vitro antitumor potential of Bulgarian Tanacetum vulgare L. on human breast adenocarcinoma cells
Kothapalli et al.	2014	Phytopharmacology of Ficus bengalensis-A review
CN104383392A (zh)	2015-03-04	一种预防和治疗家禽胃肠道寄生虫的中兽药
EP2438924A4 (de)	2013-10-30	Pharmazeutische zusammensetzungen mit kräuterextrakten zur prävention oder behandlung von nephritis
Nigam et al.	2011	Hepatoprotective activity of Chenopodium album Linn. against alcohol induced liver damage
Origbemisoye et al.	2020	Immunomodulatory foods and functional plants for COVID-19 prevention: A review
CN110882340A (zh)	2020-03-17	一种治疗因气血双虚所致的腹胀和浮肿的中药组合物
Kiran et al.	2021	Australian Ethnomedicinal Plant Extracts Promote Apoptosis-Mediated Cell Death in Human Hepatocellular Carcinoma in vitro
CN101744265A (zh)	2010-06-23	一种保健茶的制作方法